Blood Cancer United Celebrates Champions at First Night of Champions Event in New York

Blood Cancer United Hosts Inaugural Night of Champions

Blood Cancer United launched its first-ever Night of Champions on October 9, 2026, during the reimagined Breakthroughs Summit, held at the New York Marriott Marquis. This landmark event recognized outstanding contributions to the blood cancer community through the introduction of two significant awards: the Breakthrough Voice Award and the Breakthrough Rising Leader Award. These awards aim to honor individuals who are making substantial strides in understanding blood cancer and enhancing the experiences of patients and families.

The Event's Significance

The Night of Champions brought together a wide array of participants including researchers, survivors, volunteers, patients, philanthropic leaders, and corporate partners. This collaborative atmosphere was designed to galvanize efforts toward achieving Blood Cancer United’s ambitious goal of adding one million years of life for blood cancer patients by the year 2040.

Dr. E. Anders Kolb, CEO of Blood Cancer United, emphasized the importance of recognizing those who are at the forefront of progress in the blood cancer arena. "The inaugural Night of Champions celebrates the people behind progress,” Kolb noted. “We could not imagine two more fitting recipients for our first-ever Breakthrough Voice and Breakthrough Rising Leader Award than Dr. Mukherjee and Charlotte.”

Honoring Dr. Siddhartha Mukherjee

Dr. Siddhartha Mukherjee, an acclaimed physician-scientist and Pulitzer Prize-winning author, was awarded the Breakthrough Voice Award. His extensive contributions to cancer research and patient care have significantly impacted how society understands blood cancer. In his acceptance speech, he articulated the transformative evolution in treatments for blood cancers, citing that advancements have extended beyond hematological malignancies to reshaping approaches in the treatment of various cancers. "Blood cancers are among the most lethal malignancies, yet we have made radical advances in treating and even curing some of them," Dr. Mukherjee stated.

His commitment to helping patients, especially underserved populations in India and South Asia, depicts the intersection of compassion and scientific inquiry evident in his work.

Celebrating Young Leadership

In a notable highlight of the evening, the Breakthrough Rising Leader Award was presented to 15-year-old Charlotte Nathanson, a two-time survivor of acute myeloid leukemia. Nathanson’s dynamic advocacy and personal journey demonstrate a remarkable commitment to improving the lives of children afflicted with cancer. "Surviving leukemia twice helped me understand what I want to do with my life... Everything I do is driven by the hope that the next child and family facing blood cancer will have an easier journey and a brighter future," Nathanson shared during her speech.

Her aspirations to become a pediatric oncologist further exemplify how personal experiences can drive advocacy and make a significant impact in the medical field.

The Continued Quest for Breakthroughs

The Night of Champions was just the beginning of the 2026 Breakthroughs Summit, which aims to spotlight scientific advancements in blood cancer research. Following the ceremony, the summit will delve into discussions on breakthroughs and aims to foster innovative partnerships among researchers, advocates, and corporate partners.

This year’s research programming included the presentation of the Breakthroughs Summit Mission Impact Award to Dr. Sarah K. Tasian, a prominent pediatric oncologist whose research has propelled significant discoveries in treating high-risk leukemias and enhancing patient care. Dr. Tasian expressed gratitude for the recognition, highlighting how Blood Cancer United’s support has been instrumental in propelling her research initiatives.

A Toast to the Future

The inaugural Night of Champions, expertly hosted by Savannah Sellers from NBC News, featured stories of hope, resilience, and the collective strength of the blood cancer community. Support for the event was generously provided by Royalty Pharma and Lilly, underscoring the collaborative spirit necessary to tackle the daunting challenges faced by blood cancer patients.

Blood Cancer United exemplifies a model of advocacy that not only recognizes past achievements but energizes all stakeholders to strive for an innovative, inclusive future. This event serves not just as a celebration but as a catalyst for ongoing progress and a continued commitment to enhancing the lives of those affected by blood cancers.

With vital partnerships and a renewed focus on research, Blood Cancer United affirms its pivotal role in transforming the narrative surrounding blood cancer and advocating for better outcomes for patients everywhere.